Galvez says first dose vaccination of 70M people achievable by November | Inquirer News

Galvez says first dose vaccination of 70M people achievable by November

By: - Reporter / @KAguilarINQ
/ 09:44 AM July 08, 2021

Galvez says first dose vaccination of 70 million people achievable by November

FILE PHOTO: Presidential Adviser on Peace Process, National Task Force against Coronavirus Disease-2019 (NTF COVID-19) chief implementer and vaccine czar Carlito Galvez Jr. gives updates to President Rodrigo Duterte during a meeting with the Inter-Agency Task Force on the Emerging Infectious Diseases (IATF-EID) core members at the Arcadia Active Lifestyle Center in Matina, Davao City on January 25, 2021. KARL ALONZO/ PRESIDENTIAL PHOTO

MANILA, Philippines — Vaccine czar Carlito Galvez Jr. said Thursday that “realistically speaking,” the Philippines may attain the first dose vaccination of 70 million people against COVID-19 by November.

This comes after repeated pronouncements of government officials that the country may reach herd immunity before the end of this year or until January 2022 at the most.


“Realistically speaking, ‘yung 70 million, kaya po namin ‘yan. 70 million, first dose. ‘Yan ang target namin makuha namin before November. Sa ngayon, nakikita namin makukuha ‘yan,” Galvez said in an interview over ABS-CBN News Channel.


(Realistically speaking, we can achieve 70 million. 70 million as the first dose. That’s the target before November. Right now, we think it’s achievable.)

The World Health Organization advocates for countries to inoculate 10 percent of their population by September, 40 percent by the end of the year, and 70 percent by June next year.

READ: Countries must vaccinate 85% of population ‘or beyond’ amid virus variants — WHO exec

As of May 1 this year, the Philippine population has surpassed 109 million. sought clarification from Health Secretary Francisco Duque III on whether herd immunity requires full vaccination of at least 70% of the population.

According to Duque, “Fully vaccinated (with) 2 doses dapat, otherwise no such a thing as first dose herd immunity.”


Galvez admits that the Philippines’ target is “ambitious,” but he expressed optimism that it can be accomplished. He noted that setting such a challenging goal will push the government to its “limit” in terms of conducting vaccinations.

“Mas maganda po mas mataas ang ating standard at target. At least kung mag-fail man tayo by half o ano, makukuha pa rin natin ‘yung WHO [target] na 40 percent,” Galvez said.

(It’s better to set our standard and target high. At least if we fall by half or what, we could still reach the WHO target of 40 percent.)

“Ginawa talaga namin very ambitious so we can inspire and push the LGUs [local government units] and the national government to its limit and its potentials. At nakikita namin, kaya ‘yung 500,000 daily. Kayang-kaya,” he added.

(That’s why we made the target ambitious so we can inspire and push the LGUs and the national government to its limit and its potentials. And we see that we can really achieve the 500,000 daily vaccinations. It’s really achievable.)

The Philippines has administered 12 million COVID-19 vaccine doses out of the 17 million jabs it has received so far.

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

Early this week, however, several LGUs announced a stoppage to first dose inoculation of their constituents due to a shortage of COVID-19 vaccine supplies.


For more news about the novel coronavirus click here.
What you need to know about Coronavirus.
For more information on COVID-19, call the DOH Hotline: (02) 86517800 local 1149/1150.

The Inquirer Foundation supports our healthcare frontliners and is still accepting cash donations to be deposited at Banco de Oro (BDO) current account #007960018860 or donate through PayMaya using this link.

TAGS: COVID-19, vaccine

© Copyright 1997-2024 | All Rights Reserved

We use cookies to ensure you get the best experience on our website. By continuing, you are agreeing to our use of cookies. To find out more, please click this link.